CIK 0001937653
ZYME Zymeworks Inc.
Insider trading from SEC Form 4. Last filing 28 h ago.
Last 90 days
Net insider value
-$358k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
1
$358k by 1 insider
Insiders on file
10
with a Form 4 at this company
Signals
Open-market buys and sells at Zymeworks Inc., scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 25Weak | sell | Schayowitz Adam EVP, Head of R&D | $358k | 13,832 | -37% | - | |
| 35Weak | buy | EcoR1 Capital, LLC director, owner | $1.9M | 130,309 | +1% | - |
Transactions
The last 15 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | Schayowitz Adam EVP, Head of R&D | MOption exercise Common Stock | +37,037 | $0.00 | $0 | 37,037 | 28 h ago |
| Oct 9, 2026 | Schayowitz Adam EVP, Head of R&D | SOpen-market sale Common Stock | -13,832 | $25.85 | $358k | 23,205 | 28 h ago |
| Oct 9, 2026 | Schayowitz Adam EVP, Head of R&D | MOption exercise Restricted Stock Unitderivative | -37,037 | $0.00 | $0 | 74,074 | 28 h ago |
| Dec 24, 2024 | EcoR1 Capital, LLC director, owner | POpen-market purchase Common Stockindirect: See Note | +11,958 | $14.12 | $169k | 14,704,239 | Dec 27, 2024 |
| Dec 26, 2024 | EcoR1 Capital, LLC director, owner | POpen-market purchase Common Stockindirect: See Note | +16,692 | $14.38 | $240k | 14,720,931 | Dec 27, 2024 |
| Dec 27, 2024 | EcoR1 Capital, LLC director, owner | POpen-market purchase Common Stockindirect: See Note | +101,659 | $14.49 | $1.5M | 14,822,590 | Dec 27, 2024 |
| Dec 26, 2023 | EcoR1 Capital, LLC owner | POpen-market purchase Pre-Funded Warrantsderivativeindirect: See note | +5,086,521 | $9.83 | $50M | 5,086,521 | Dec 23, 2024 |
| Dec 10, 2024 | Campoy Carlos director | AGrant or award Stock Option (Right to Buy)derivative | +31,000 | $0.00 | $0 | 31,000 | Dec 12, 2024 |
| Dec 10, 2024 | Cesano Alessandra director | AGrant or award Stock Option (Right to Buy)derivative | +31,000 | $0.00 | $0 | 31,000 | Dec 12, 2024 |
| Dec 10, 2024 | Cox Troy director | AGrant or award Stock Option (Right to Buy)derivative | +31,000 | $0.00 | $0 | 31,000 | Dec 12, 2024 |
| Dec 10, 2024 | Davidson Nancy director | AGrant or award Stock Option (Right to Buy)derivative | +31,000 | $0.00 | $0 | 31,000 | Dec 12, 2024 |
| Dec 10, 2024 | Gallagher Neil director | AGrant or award Stock Option (Right to Buy)derivative | +31,000 | $0.00 | $0 | 31,000 | Dec 12, 2024 |
| Dec 10, 2024 | Mahony Susan director | AGrant or award Stock Option (Right to Buy)derivative | +31,000 | $0.00 | $0 | 31,000 | Dec 12, 2024 |
| Dec 10, 2024 | Miller Derek John Michael director | AGrant or award Stock Option (Right to Buy)derivative | +31,000 | $0.00 | $0 | 31,000 | Dec 12, 2024 |
| Dec 10, 2024 | Neu Kelvin director | AGrant or award Stock Option (Right to Buy)derivative | +31,000 | $0.00 | $0 | 31,000 | Dec 12, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Campoy Carlosdirector
- Cesano Alessandradirector
- Cox Troydirector
- Davidson Nancydirector
- EcoR1 Capital, LLCowner, director
- Gallagher Neildirector
- Mahony Susandirector
- Miller Derek John Michaeldirector
- Neu Kelvindirector
- Schayowitz AdamEVP, Head of R&D
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.